These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24723218)

  • 21. Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial.
    Moazen-Zadeh E; Bayanati S; Ziafat K; Rezaei F; Mesgarpour B; Akhondzadeh S
    J Psychopharmacol; 2020 May; 34(5):506-513. PubMed ID: 32122230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe SE; French P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TRE; Davies L; Kingdon D;
    Lancet Psychiatry; 2018 Aug; 5(8):633-643. PubMed ID: 30001930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
    Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
    Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of psychosocial treatments on symptoms and functional domains in schizophrenia spectrum disorders: a prospective study in a real-world setting.
    Bozzatello P; Bellino S; De Marzi G; Macrì A; Piterà R; Montemagni C; Rocca P
    Disabil Rehabil; 2019 Nov; 41(23):2799-2806. PubMed ID: 29986607
    [No Abstract]   [Full Text] [Related]  

  • 25. Group cognitive-behavioural therapy for schizophrenia. Randomised controlled trial.
    Barrowclough C; Haddock G; Lobban F; Jones S; Siddle R; Roberts C; Gregg L
    Br J Psychiatry; 2006 Dec; 189():527-32. PubMed ID: 17139037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.
    Weiser M; Levi L; Zamora D; Biegon A; SanGiovanni JP; Davidson M; Burshtein S; Gonen I; Radu P; Slobozean Pavalache K; Nastas I; Hemi R; Ryan T; Davis JM
    JAMA Psychiatry; 2019 Oct; 76(10):1009-1017. PubMed ID: 31365044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
    Hansbauer M; Wobrock T; Kunze B; Langguth B; Landgrebe M; Eichhammer P; Frank E; Cordes J; Wölwer W; Winterer G; Gaebel W; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Malchow B; Strube W; Schneider-Axmann T; Falkai P; Hasan A
    Psychiatry Res; 2018 May; 263():22-29. PubMed ID: 29482042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial.
    Littlewood E; Duarte A; Hewitt C; Knowles S; Palmer S; Walker S; Andersen P; Araya R; Barkham M; Bower P; Brabyn S; Brierley G; Cooper C; Gask L; Kessler D; Lester H; Lovell K; Muhammad U; Parry G; Richards DA; Richardson R; Tallon D; Tharmanathan P; White D; Gilbody S;
    Health Technol Assess; 2015 Dec; 19(101):viii, xxi-171. PubMed ID: 26685904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial.
    Röhricht F; Priebe S
    Psychol Med; 2006 May; 36(5):669-78. PubMed ID: 16608559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis.
    Uttley L; Stevenson M; Scope A; Rawdin A; Sutton A
    BMC Psychiatry; 2015 Jul; 15():151. PubMed ID: 26149275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
    Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
    Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical study of dance art therapy on hospitalized patients with chronic schizophrenia.
    Kong Y; Min H; Zhu X; Zhang L; Hu J
    Medicine (Baltimore); 2024 Jun; 103(24):e37393. PubMed ID: 38875423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT.
    Holt RI; Hind D; Gossage-Worrall R; Bradburn MJ; Saxon D; McCrone P; Morris TA; Etherington A; Shiers D; Barnard K; Swaby L; Edwardson C; Carey ME; Davies MJ; Dickens CM; Doherty Y; French P; Greenwood KE; Kalidindi S; Khunti K; Laugharne R; Pendlebury J; Rathod S; Siddiqi N; Wright S; Waller G; Gaughran F; Barnett J; Northern A
    Health Technol Assess; 2018 Nov; 22(65):1-160. PubMed ID: 30499443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based comprehensive intervention for people with schizophrenia in Guangzhou, China: Effects on clinical symptoms, social functioning, internalized stigma and discrimination.
    Li J; Huang YG; Ran MS; Fan Y; Chen W; Evans-Lacko S; Thornicroft G
    Asian J Psychiatr; 2018 Apr; 34():21-30. PubMed ID: 29627721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.
    Wagner E; Wobrock T; Kunze B; Langguth B; Landgrebe M; Eichhammer P; Frank E; Cordes J; Wölwer W; Winterer G; Gaebel W; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Siskind D; Malchow B; Strube W; Schneider-Axmann T; Falkai P; Hasan A
    Schizophr Res; 2019 Jun; 208():370-376. PubMed ID: 30704862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.